Brian J Blyth

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Traumatic alterations in consciousness: traumatic brain injury
    Brian J Blyth
    Department of Emergency Medicine, Center for Neural Development and Disease, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 645, Rochester, NY 14642, USA
    Emerg Med Clin North Am 28:571-94. 2010
  2. doi Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury
    Brian J Blyth
    Department of Emergency Medicine and Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Neurotrauma 28:2453-62. 2011
  3. pmc Validation of serum markers for blood-brain barrier disruption in traumatic brain injury
    Brian J Blyth
    Department of Emergency Medicine and Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York, USA
    J Neurotrauma 26:1497-1507. 2009

Detail Information

Publications3

  1. pmc Traumatic alterations in consciousness: traumatic brain injury
    Brian J Blyth
    Department of Emergency Medicine, Center for Neural Development and Disease, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 645, Rochester, NY 14642, USA
    Emerg Med Clin North Am 28:571-94. 2010
    ..Although definitive evidence is lacking, mTBI is likely to be related to significant long-term sequelae such as Alzheimer disease and other neurodegenerative processes...
  2. doi Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury
    Brian J Blyth
    Department of Emergency Medicine and Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York 14642, USA
    J Neurotrauma 28:2453-62. 2011
    ..We conclude that peripheral release of S100B after multi-trauma is probably negligible and that UCHL1 may have some utility to monitor BBB disruption following TBI...
  3. pmc Validation of serum markers for blood-brain barrier disruption in traumatic brain injury
    Brian J Blyth
    Department of Emergency Medicine and Center for Neural Development and Disease, University of Rochester Medical Center, Rochester, New York, USA
    J Neurotrauma 26:1497-1507. 2009
    ..511-1.089). Using an S100B concentration cutoff of 0.027 ng=ml, specificity for abnormal Q(A) was 90% or higher at each time point. We conclude that serum S100B concentrations accurately indicate BBB dysfunction at 12 h after TBI...